1-13 of 13
Philippe Bourin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects Of a Novel Ceramic Biomaterial On Immune Modulatory Properties and Differentiation Potential Of Mesenchymal Stromal Cells

Giulio Bassi, Cedric Menard, Fabien Guilloton, Luciano Pacelli, Roberta Carusone, Mariano Di Trapani, Jasmina Zanoncello, Francesco Bifari, Luc Sensebé, Fredric Deschaseaux, Serge Baroth, Hubert Schrezenmeier, MD, Markus Rojewski, Pierre Layrolle, Rosaria Giordano, MD, Lazzari Lorenza, Cristiana Lavazza, PhD, Philippe Bourin, Karin Tarte, PharmD, PhD, Mauro Krampera, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4858.
https://doi.org/10.1182/blood.V122.21.4858.4858
Published: 2013
Journal Articles

Are Stromal Cells of Adipose Tissue From Multiple Myeloma Patients Are Normal ? A Comparison of Adipose Derived Stromals Cells From Healthy Donors and Multiple Myeloma Patients

Benjamin Hebraud, MD, Elodie Labat, Nicolas Espagnolle, Melanie Gadelorge, Louis Casteilla, Luc Sensebé, Murielle Roussel, MD, Anne Huynh, MD, marie-Veronique Joubert, Jill Corre, Herve avet-Loiseau, MD, Michel Attal, MD, Philippe Bourin
Journal: Blood
Blood (2012) 120 (21): 3993.
https://doi.org/10.1182/blood.V120.21.3993.3993
Published: 2012
Journal Articles

Comparison of Stromal Cells of Adipose Tissue From Multiple Myeloma Patients and Healthy Donors

Benjamin Hébraud, Elodie Labat, Nicolas Espagnolle, Jill Corre, Michel Attal, Philippe Bourin
Journal: Blood
Blood (2010) 116 (21): 2979.
https://doi.org/10.1182/blood.V116.21.2979.2979
Published: 2010
Journal Articles

GMP-Grade Large-Scale Expansion of Bone-Marrow- (BM) Derived Human Mesenchymal Stem/Stroma Cells (MSC): Comparison of Efficacy of Different Expansion Systems and Role of Cytokines/Chemokines

Markus Rojewski, Natalie Fekete, Daniel Fuerst, Philippe Bourin, Ramin Lotfi, Volker Mailaender, Gerlinde Schmidtke-Schrezenmeier, Luc Sensebé, Hubert Schrezenmeier
Journal: Blood
Blood (2010) 116 (21): 337.
https://doi.org/10.1182/blood.V116.21.337.337
Published: 2010
Journal Articles

Growth Differentation Factor 15 Is a Survival Factor for multiple myeloma cells and its plasma Concentration In Patients Is Related to Reduced Survival

Jill Corre, Elodie Labat, Nicolas Espagnolle, Hervé Avet-Loiseau, Murielle Roussel, Anne Huynh, Melanie Gadelorge, Patrick Laharrague, Philippe Moreau, Thierry Facon, Fournié Jean-Jacques, Michel Attal, Philippe Bourin
Journal: Blood
Blood (2010) 116 (21): 614.
https://doi.org/10.1182/blood.V116.21.614.614
Published: 2010
Journal Articles

Growth Differentiation Factor 15 Plasma Level in patients with Multiple Myeloma: A Study of Intergroupe Francophone Du Myelome

Jill Corre, Murielle Roussel, Anne Huynh, Melanie Gadelorge, Elodie Labat, Patrick Laharrague, Philippe Moreau, Thierry Facon, Hervé Avet-Loiseau, Jean-Jacques Fournié, Michel Attal, Philippe Bourin
Journal: Blood
Blood (2008) 112 (11): 2700.
https://doi.org/10.1182/blood.V112.11.2700.2700
Published: 2008
Journal Articles

CD200 is a new prognostic factor in multiple myeloma

Clinical Trials & Observations
Jerome Moreaux, Dirk Hose, Thierry Reme, Eric Jourdan, Michael Hundemer, Eric Legouffe, Philippe Moine, Philippe Bourin, Marion Moos, Jill Corre, Thomas Möhler, John De Vos, Jean Francois Rossi, Hartmut Goldschmidt, Bernard Klein
Journal: Blood
Blood (2006) 108 (13): 4194–4197.
https://doi.org/10.1182/blood-2006-06-029355
Published: 2006
Includes: Supplemental data
Journal Articles

Characterization of Mesenchymal Stem Cells Abnormalities in Multiple Myeloma.

Philippe Bourin, MD, PhD, Jill Corre, PharmD, Karène Mahtouk, PhD, Mélanie Gadelorge, Ing, Patrick Laharrague, MD, PhD, Bernard Klein, PhD, Thierry Rème, MD, PhD, Michel Attal, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 511.
https://doi.org/10.1182/blood.V108.11.511.511
Published: 2006
Journal Articles

CD200 Is a New Prognostic Factor in Multiple Myeloma.

Jerome Moreaux, Dirk Hose, Thierry X. Reme, Eric Jourdan, Michael Hundemer, Legouffe Eric, Philippe Moine, Philippe Bourin, Marion Moos, Jill Corre, Thomas Mölher, John DeVos, Jean-Francois Rossi, Hartmut Goldschmidt, Bernard Klein
Journal: Blood
Blood (2006) 108 (11): 4997.
https://doi.org/10.1182/blood.V108.11.4997.4997
Published: 2006
Journal Articles

Stem Cell Factor (SCF) for Hematopoietic Stem Cell (HSC) Mobilization: Results of the Randomized IFM 99-01 Trial.

Philippe Bourin, MD/PhD, Anne Huynh, MD, Christian Recher, MD, Christian Berthou, MD, Laurent Garderet, MD, Lofti Benbouker, MD, Anne-Marie Perry, MD, Thierry Facon, MD, Cyrille Hulin, MD, Jean-Jacques Sotto, MD, Laurent Voillat, MD, Mauricette Michallet, MD, Michel Attal, MD.
Journal: Blood
Blood (2004) 104 (11): 2921.
https://doi.org/10.1182/blood.V104.11.2921.2921
Published: 2004
Journal Articles

Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival

Francis Hérodin, Philippe Bourin, Jean-François Mayol, Jean-Jacques Lataillade, Michel Drouet
Journal: Blood
Blood (2003) 101 (7): 2609–2616.
https://doi.org/10.1182/blood-2002-06-1634
Published: 2003
Journal Articles

Stromal cell–derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G 0 /G 1 transition in CD34 + cells: evidence for an autocrine/paracrine mechanism

Jean-Jacques Lataillade, Denis Clay, Philippe Bourin, Françis Hérodin, Catherine Dupuy, Claude Jasmin, Marie-Caroline Le Bousse-Kerdilès
Journal: Blood
Blood (2002) 99 (4): 1117–1129.
https://doi.org/10.1182/blood.V99.4.1117
Published: 2002
Journal Articles

Chemokine SDF-1 enhances circulating CD34 + cell proliferation in synergy with cytokines: possible role in progenitor survival

Jean-Jacques Lataillade, Denis Clay, Catherine Dupuy, Sylvain Rigal, Claude Jasmin, Philippe Bourin, Marie-Caroline Le Bousse-Kerdilès
Journal: Blood
Blood (2000) 95 (3): 756–768.
https://doi.org/10.1182/blood.V95.3.756
Published: 2000